Review



physical function (pf) 20a  (ProMIS Neurosciences)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    ProMIS Neurosciences physical function (pf) 20a
    Physical Function (Pf) 20a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/physical+function+20a/physical+function+20a/pm38460544-47-8-7
    Average 90 stars, based on 1 article reviews
    physical function (pf) 20a - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Patient-reported outcome measures for physical function in cancer patients: content comparison of the EORTC CAT Core, EORTC QLQ-C30, SF-36, FACT-G, and PROMIS measures using the International Classification of Functioning, Disability and Health.
    Article Snippet: PROMIS – short form v2.0 – physical function 20a The PROMIS Physical Function 20a [13] is a generic short-form based on the PROMIS Physical Function Item Bank v2.0 [34].

    Article Title: Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease
    Article Snippet: Among the various PRO measures used in this study, PROMIS Physical Function 20a is an important tool for measuring physical function in patients with LOPD and has previously shown validity for use in LOPD [ ].

    Article Title: Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group.
    Article Snippet: Background: A series of qualitative studies conducted by the OMERACT Myositis Working Group identified pain interference, fatigue, and physical function as highly important life impact domains for adults with idiopathic inflammatory myositis (IIM).. In this study, our goal was to assess the responsiveness and minimal important difference of PROMIS pain interference (6a), fatigue (7a), and physical function (8b).. Methods: Adults with IIM from USA, Netherlands, Korea, Sweden, and Australia with two "clinical" visits were enrolled in this prospective study.

    Article Title: Understanding the Multilevel Disability Self-Management Strategies of Puerto Rican Older Men
    Article Snippet: Quantitative results The PROMIS Physical Function 20a Short Form T-scores ranged from 30.1 to 43.1 (3 to .5 SD below the general population) with an average of 37.2 (see ).

    Article Title: A patient-centred assessment of the 2016 ACR-EULAR Myositis Response Criteria: evaluating the meaningfulness of responses.
    Article Snippet: Objectives: The ACR-EULAR Myositis Response Criteria [Total Improvement Score (TIS)] is a composite measure calculated using changes in myositis core set measures.. It is unclear if achieving improvement per TIS reflects improvement in any symptoms of patients with myositis.. In this study, we examined the association between achieving TIS improvement and patient-centred outcome measures (PCOMs).


    Standard Deviation:

    Article Title: Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2).
    Article Snippet: .. For the PROMIS Physical Function 20a instrument, the summary T-score is a standardized measure with a population average score of 50 and standard deviation of 10. ..



    Similar Products

    physical function (pf) 20a  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences physical function (pf) 20a
    Physical Function (Pf) 20a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/physical+function+20a/physical+function+20a/pm38460544-47-8-7
    Average 90 stars, based on 1 article reviews
    physical function (pf) 20a - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    physical function-short form 20a  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences physical function-short form 20a
    Physical Function Short Form 20a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/physical+function+20a/promis+pf+20/pmc11994948-152-32-34
    Average 90 stars, based on 1 article reviews
    physical function-short form 20a - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    v1.2 physical function 20a spanish  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences v1.2 physical function 20a spanish
    V1.2 Physical Function 20a Spanish, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/physical+function+20a/v1+2+physical+function+short+form+20a/10__3390_slash_technologies12110232-86-30-29
    Average 90 stars, based on 1 article reviews
    v1.2 physical function 20a spanish - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    physical function short form 20a  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences physical function short form 20a
    Patient-level responder analysis ( A ) and group-level analysis ( B ) of PROMIS physical and fatigue domains and R-PAct <t>outcomes</t> in ERT-experienced patients. Patients with a change from baseline >0 in PROMIS Physical Function or R-PAct, or <0 for PROMIS Fatigue, were classed as ‘responders.’ *For the Fatigue endpoint, a negative change from the baseline value indicated a better health outcome. alg alglucosidase alfa, CFBL change from baseline, CI confidence interval, cipa cipaglucosidase alfa, ERT enzyme replacement therapy, LS least squares, mig miglustat, pbo placebo, PROMIS Patient-Reported Outcome <t>Measurement</t> <t>Information</t> <t>System,</t> R-Pact Rasch-built Pompe-specific Activity
    Physical Function Short Form 20a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/physical+function+20a/promis+pf+20/pmc11561219-14-11-15
    Average 90 stars, based on 1 article reviews
    physical function short form 20a - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    physical function 20a  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences physical function 20a
    Patient-level responder analysis ( A ) and group-level analysis ( B ) of PROMIS physical and fatigue domains and R-PAct <t>outcomes</t> in ERT-experienced patients. Patients with a change from baseline >0 in PROMIS Physical Function or R-PAct, or <0 for PROMIS Fatigue, were classed as ‘responders.’ *For the Fatigue endpoint, a negative change from the baseline value indicated a better health outcome. alg alglucosidase alfa, CFBL change from baseline, CI confidence interval, cipa cipaglucosidase alfa, ERT enzyme replacement therapy, LS least squares, mig miglustat, pbo placebo, PROMIS Patient-Reported Outcome <t>Measurement</t> <t>Information</t> <t>System,</t> R-Pact Rasch-built Pompe-specific Activity
    Physical Function 20a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/physical+function+20a/physical+function+20a/pmc11561219-105-9-9
    Average 90 stars, based on 1 article reviews
    physical function 20a - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    - physical function short form 20a  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences - physical function short form 20a
    PROMs included in review
    Physical Function Short Form 20a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/physical+function+20a/promis+pf+20/pmc11225496-130-1-0
    Average 90 stars, based on 1 article reviews
    - physical function short form 20a - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Patient-level responder analysis ( A ) and group-level analysis ( B ) of PROMIS physical and fatigue domains and R-PAct outcomes in ERT-experienced patients. Patients with a change from baseline >0 in PROMIS Physical Function or R-PAct, or <0 for PROMIS Fatigue, were classed as ‘responders.’ *For the Fatigue endpoint, a negative change from the baseline value indicated a better health outcome. alg alglucosidase alfa, CFBL change from baseline, CI confidence interval, cipa cipaglucosidase alfa, ERT enzyme replacement therapy, LS least squares, mig miglustat, pbo placebo, PROMIS Patient-Reported Outcome Measurement Information System, R-Pact Rasch-built Pompe-specific Activity

    Journal: Journal of Patient-Reported Outcomes

    Article Title: Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease

    doi: 10.1186/s41687-024-00805-w

    Figure Lengend Snippet: Patient-level responder analysis ( A ) and group-level analysis ( B ) of PROMIS physical and fatigue domains and R-PAct outcomes in ERT-experienced patients. Patients with a change from baseline >0 in PROMIS Physical Function or R-PAct, or <0 for PROMIS Fatigue, were classed as ‘responders.’ *For the Fatigue endpoint, a negative change from the baseline value indicated a better health outcome. alg alglucosidase alfa, CFBL change from baseline, CI confidence interval, cipa cipaglucosidase alfa, ERT enzyme replacement therapy, LS least squares, mig miglustat, pbo placebo, PROMIS Patient-Reported Outcome Measurement Information System, R-Pact Rasch-built Pompe-specific Activity

    Article Snippet: PROs evaluated included the Subject’s Global Impression of Change (SGIC), Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form 20a, PROMIS Fatigue Short Form 8a, Rasch-built Pompe-specific Activity (R-PAct), and European Quality of Life-5 Dimensions 5 Response Levels (EQ-5D-5L).

    Techniques: Activity Assay

    PROMs included in review

    Journal: Orphanet Journal of Rare Diseases

    Article Title: Measuring health related quality of life (HRQoL) in Lysosomal Storage Disorders (LSDs): a rapid scoping review of available tools and domains

    doi: 10.1186/s13023-024-03256-0

    Figure Lengend Snippet: PROMs included in review

    Article Snippet: PROMIS - Physical Function Short Form 20a [ ] , , 1 , N , Physical function , N.

    Techniques: Activity Assay, Clinical Proteomics